Robert F. Kennedy Jr. Faces Intensive Congressional Hearings as Budget, Vaccine Policy, and Public Health Strategy Take Center Stage

Multi-day Capitol Hill appearances will test HHS leadership on proposed budget cuts, vaccine guidance, and national health priorities amid heightened political and public health scrutiny

A series of high-profile congressional hearings involving Robert F. Kennedy Jr. is set to place U.S. health policy under renewed national focus, as lawmakers evaluate federal priorities spanning vaccine guidance, healthcare access, and agency funding.

Scheduled across multiple committees in both chambers of Congress, the hearings will center on the Department of Health and Human Services’ (HHS) proposed 2027 budget, as well as broader questions regarding the nation’s public health strategy. The sessions represent Kennedy’s first extended appearance on Capitol Hill in several months and are expected to provide insight into the administration’s evolving health agenda.

Trump Nominates Erica Schwartz to Lead Centers for Disease Control and Prevention Amid Push for Stability and Scientific Credibility

Selection of a career physician and former deputy surgeon general signals a potential pivot toward traditional public health leadership as the CDC navigates workforce challenges, vaccine policy scrutiny, and institutional recovery

The nomination of Erica Schwartz to serve as director of the Centers for Disease Control and Prevention marks a pivotal moment for the nation’s leading public health agency, as policymakers and health experts assess the future direction of federal disease prevention and response efforts.

Announced by Donald Trump, the selection positions Schwartz—a physician with extensive experience in military and federal health systems—as a candidate aligned with established public health frameworks. Her background includes serving as deputy surgeon general during Trump’s first administration, as well as leadership roles within the U.S. Coast Guard’s health system and the U.S. Public Health Service Commissioned Corps.

Public health analysts note that Schwartz’s nomination reflects a broader effort to restore continuity and institutional stability at the CDC following a period of leadership turnover, workforce disruptions, and heightened scrutiny over federal vaccine policies. The agency has faced operational and morale challenges in recent years, compounded by public debate surrounding pandemic response strategies and evolving health communication practices.